{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Myeloma Minutes","title":"035 Blood Clots and Myeloma - What Every Patient Should Know","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/2b38c887\"></iframe>","width":"100%","height":180,"duration":1671,"description":"This episode explains why people with myeloma are at higher risk of blood clots, how blood thinners help, and the warning signs patients and carers should never ignore.\n📌Key Takeaways:\n\nMyeloma and some myeloma treatments can increase the risk of dangerous blood clots.\nSimple steps like staying hydrated, keeping mobile and taking blood thinners correctly really matter.\nLeg swelling, chest pain or sudden breathlessness should never be ignored : Fast treatment saves lives.\n\nFor extra content and more resources, please visit our website: https://www.themyelomaminutes.com/\nWe are proudly partnered with Myeloma UK for this episode. For more credible myeloma advice, please visit: https://www.myeloma.org.uk/\nThe Myeloma UK InfoLine is: 0800 980 3332\nThis podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns\n \nABOUT YOUR HOSTS\nDr. Jam Kothari\nDr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.\n \nDr. Sally Moore\nDr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients.  She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and...","thumbnail_url":"https://img.transistorcdn.com/rD-uEWjDenF-XROyoth2QyT0dpCjh2HWCm0evlIF6_g/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wNDJl/MDM4NjA4NWE3NDkx/OTRkYzVkYzYxODIx/ZWI4YS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}